DV
Dividend Vision

NBP — NovaBridge Biosciences

NovaBridge Biosciences (NBP)

Total return is -84.3% over the past 6.6 years, 240.9 points behind SPY at 156.6%. Its deepest 1-year drawdown was 77.6%.

NovaBridge Biosciences is an equity fund that focuses on biosciences stocks. The fund does not currently maintain a distribution rate or publicly available expense ratio information. It may appeal to investors seeking exposure to the biosciences sector, though potential investors should note that limited data is available regarding its yield profile and cost structure.

NBP key facts

Asset type
Stock
Asset class
Equity
Inception date
01/17/2020
Last close
$1.96
Market cap
$211,636,768
Average volume
331100.0
Beta
1.453
Payout ratio
0.0
Forward P/E
2.6838
EPS
$-0.50